Approach to Sustainability
CSR Basic Policy
We contribute to the development of a society in which everyone can live in health
by conducting business activities based on the Alfresa Group’s principles
and by addressing social and environmental agendas.
2019-21 ESG Important Issues
The Alfresa Group set forth “ESG Important Issues” in the 2019-21 Mid-term Management Plan.
We will contribute to a sustainable society through sustained growth.
CSR Activities Policy / Initiatives
|Give consideration to the environment||Respect human rights and realize a fulfilling workplace||Contribute to local communities||Strengthen management foundations which support growth (Corporate governance)||Improve and strengthen business foundations (Compliance & risk management)|
|Use energy efficiently
Reduce greenhouse gas emissions
|Respect human rights
Advance work-life balance
Prepare a comfortable work environment and promote health
|Actively contribute to society
Contribute to the realization of harmonious coexistence with local communities
|Enhance and strengthen the corporate governance system
Implement optimal capital policies
Enhance information disclosure
|Promote and thoroughly implement compliance
Promote and strengthen risk management
Enhance and strengthen disaster countermeasures
CSR Promotion Structure
The Group has established a structure to promote CSR throughout the Group. The CSR Promotion Committee, chaired by Director, Senior Vice President & Executive Officer of Alfresa Holdings Corporation and comprising members selected from the management of Alfresa Holdings Corporation and its Group companies, has been established and meets regularly twice per year to discuss important policies and other issues related to the Group’s overall CSR activities and to carry out reporting and evaluation of activities based on the action plans at Group companies. Alfresa Holdings Corporation and its Group companies also hold CSR Conferences regularly with the aim of promoting CSR activities at each company.
Alfresa Group CSR Management Framework
Participation in Industry Groups and External Organizations
The Alfresa Group aims to become a Healthcare Consortium that provides products and services in every health-related field, and actively participates in various industry groups and external organizations.
Main Industry Groups and External Organizations
- Keidanren (Japan Business Federation), Corporate Member
- The Federation of Japan Pharmaceutical Wholesalers Association (JPWA), Member
- Japan Association for the World Food Programme, Councilor
Communicating with Stakeholders
The Group will steadily promote CSR activities by having all of its people properly understand and implement the Group’s principles in the form of Our Philosophy, Our Vision, and Our Promises, while practicing two-way communication with its various stakeholders.
|Stakeholders||Communication approach||Main means of communication|
|Customers and Suppliers||Serving as a bridge between customers and suppliers, the Group collects information about pharmaceuticals (efficacy and side effects) as well as opinions and requests from customers, and then provides this information to suppliers. The Group also holds seminars and events on themes that are useful for customers and suppliers respectively to provide opportunities for solving health and healthcare-related issues and sharing information.||
|Our People*||The Group shares information through the Group newsletter and other tools, and implements Group-wide initiatives to spread and ensure the practice of the Group’s principles.||
|Global Environment||The Group strives to reduce environmental impact at each stage, including the manufacturing, selling and disposing of pharmaceuticals and other products, and it fully discloses information on its environmental impact.||
|Local Communities||The Group is aware of its social responsibilities as a corporate citizen that exists in and develops together with society. In addition to contributing to healthcare in the society through its business activities with close links to local communities, it conducts social contribution activities proactively, aiming for harmonious coexistence with local communities.||
|Shareholders and Investors||In order to deliver the appropriate information to all shareholders and investors, we provide timely disclosure of information, practicing the general principles of transparency, fairness, continuity, timeliness, and interactivity.||
|Governments (National and Local Governments), Industry Groups||The Group complies with laws and regulations, including the Act on Securing Quality, Efficacy and Safety of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetics (PMD Act) and conducts itself in accordance with the Fair Competition Code of the healthcare-related industry. The Group pays its taxes properly and in a timely manner.||